Global Osteoarthritis Pain Drugs

Osteoarthritis Pain Drugs Comprehensive Study by Type (Oral, Injection, External), Application (Medical Care, Personal Care), Therapies (Non- Pharmacological Therapy, Pharmacological Therapy, Surgical Treatment), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Hospitals, Clinics, Household), Dosage Form (Solid, Liquid, Semi-Solid), Drug Class (Nsaids, Opioids, Viscosupplements, Corticosteroids, Others) Players and Region - Global Market Outlook to 2026

Osteoarthritis Pain Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Osteoarthritis Pain Drugs Market?

Osteoarthritis is also known as degenerative joint disease or degenerative arthritis is a chronic disease which is characterized by the deterioration of cartilage in the joint which results in stiffness, pain and impaired movement of bones when get rubbed together. The disease most commonly affects the joints in that knee, hands, feet and spine and relatively common in the shoulder and hip joints.

The market study is being classified by Type (Oral, Injection and External), by Application (Medical Care and Personal Care) and major geographies with country level break-up.

Pfizer Inc. (United States), Johnson & Johnson (United States), GlaxoSmithKline (United Kingdom), Mylan (United States), Eli Lilly and Company (United States), Abbott Laboratories (United States), Bioventus, Inc. (United States), Sanofi (France), Flexion Therapeutics, Inc. (United States), Alkem Laboratories (India), Anika Therapeutics, Inc. (United States), Chugai Pharmaceutical Co.( Japan) and Zimmer Biomet Holdings, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Horizon Pharma Plc (Dublin), Ferring B.V.(Switzerland), Bayer (Germany), Almatica Pharma (United States), TEVA (Isreal) and Iroko Pharmaceuticals (United States).

Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Osteoarthritis Pain Drugs market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Osteoarthritis Pain Drugs market by Type, Application and Region.

On the basis of geography, the market of Osteoarthritis Pain Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Rise in Geriatric Population
  • Increased Prevalence of Osteoarthritis Across The Globe

Market Trend
  • Rich Pipeline Of Innovative Treatment Options

Restraints
  • The Severe Side Effects Of The Drugs
  • High Cost Of Advanced Treatments

Opportunities
  • Rise in Awareness Regarding Degenerative Bone Diseases In Developing Countries

Challenges
  • Loss Of Patent Exclusivity Of Branded Therapies



According to the United Nations, "By 2050 people aged over 60 will account for more than 20% of the world’s population. Of that 20%, a conservative estimate of 15% will have symptomatic OA, and one-third of these people will be severely disabled. This means that by 2050, 130 million people will suffer from OA worldwide, of whom 40 million will be severely disabled by the disease."

Key Target Audience
Osteoarthritis Pain Drugs Manufacturers and Distributors, Healthcare Institutions (hospitals, medical schools, and outpatient clinics), Market Research and Consulting Firms, Venture Capitalists and Investors and Research & Development Companies

Report Objectives / Segmentation Covered

By Type
  • Oral
  • Injection
  • External
By Application
  • Medical Care
  • Personal Care
By Therapies
  • Non- Pharmacological Therapy
  • Pharmacological Therapy
  • Surgical Treatment

By Route of Administration
  • Oral
  • Parenteral
  • Topical

By Distribution Channel
  • Hospitals
  • Clinics
  • Household

By Dosage Form
  • Solid
  • Liquid
  • Semi-Solid

By Drug Class
  • Nsaids
  • Opioids
  • Viscosupplements
  • Corticosteroids
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Geriatric Population
      • 3.2.2. Increased Prevalence of Osteoarthritis Across The Globe
    • 3.3. Market Challenges
      • 3.3.1. Loss Of Patent Exclusivity Of Branded Therapies
    • 3.4. Market Trends
      • 3.4.1. Rich Pipeline Of Innovative Treatment Options
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Osteoarthritis Pain Drugs, by Type, Application, Therapies, Route of Administration, Distribution Channel, Dosage Form, Drug Class and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Osteoarthritis Pain Drugs (Value)
      • 5.2.1. Global Osteoarthritis Pain Drugs by: Type (Value)
        • 5.2.1.1. Oral
        • 5.2.1.2. Injection
        • 5.2.1.3. External
      • 5.2.2. Global Osteoarthritis Pain Drugs by: Application (Value)
        • 5.2.2.1. Medical Care
        • 5.2.2.2. Personal Care
      • 5.2.3. Global Osteoarthritis Pain Drugs by: Therapies (Value)
        • 5.2.3.1. Non- Pharmacological Therapy
        • 5.2.3.2. Pharmacological Therapy
        • 5.2.3.3. Surgical Treatment
      • 5.2.4. Global Osteoarthritis Pain Drugs by: Route of Administration (Value)
        • 5.2.4.1. Oral
        • 5.2.4.2. Parenteral
        • 5.2.4.3. Topical
      • 5.2.5. Global Osteoarthritis Pain Drugs by: Distribution Channel (Value)
        • 5.2.5.1. Hospitals
        • 5.2.5.2. Clinics
        • 5.2.5.3. Household
      • 5.2.6. Global Osteoarthritis Pain Drugs by: Dosage Form (Value)
        • 5.2.6.1. Solid
        • 5.2.6.2. Liquid
        • 5.2.6.3. Semi-Solid
      • 5.2.7. Global Osteoarthritis Pain Drugs by: Drug Class (Value)
        • 5.2.7.1. Nsaids
        • 5.2.7.2. Opioids
        • 5.2.7.3. Viscosupplements
        • 5.2.7.4. Corticosteroids
        • 5.2.7.5. Others
      • 5.2.8. Global Osteoarthritis Pain Drugs Region
        • 5.2.8.1. South America
          • 5.2.8.1.1. Brazil
          • 5.2.8.1.2. Argentina
          • 5.2.8.1.3. Rest of South America
        • 5.2.8.2. Asia Pacific
          • 5.2.8.2.1. China
          • 5.2.8.2.2. Japan
          • 5.2.8.2.3. India
          • 5.2.8.2.4. South Korea
          • 5.2.8.2.5. Taiwan
          • 5.2.8.2.6. Australia
          • 5.2.8.2.7. Rest of Asia-Pacific
        • 5.2.8.3. Europe
          • 5.2.8.3.1. Germany
          • 5.2.8.3.2. France
          • 5.2.8.3.3. Italy
          • 5.2.8.3.4. United Kingdom
          • 5.2.8.3.5. Netherlands
          • 5.2.8.3.6. Rest of Europe
        • 5.2.8.4. MEA
          • 5.2.8.4.1. Middle East
          • 5.2.8.4.2. Africa
        • 5.2.8.5. North America
          • 5.2.8.5.1. United States
          • 5.2.8.5.2. Canada
          • 5.2.8.5.3. Mexico
    • 5.3. Global Osteoarthritis Pain Drugs (Volume)
      • 5.3.1. Global Osteoarthritis Pain Drugs by: Type (Volume)
        • 5.3.1.1. Oral
        • 5.3.1.2. Injection
        • 5.3.1.3. External
      • 5.3.2. Global Osteoarthritis Pain Drugs by: Application (Volume)
        • 5.3.2.1. Medical Care
        • 5.3.2.2. Personal Care
      • 5.3.3. Global Osteoarthritis Pain Drugs by: Therapies (Volume)
        • 5.3.3.1. Non- Pharmacological Therapy
        • 5.3.3.2. Pharmacological Therapy
        • 5.3.3.3. Surgical Treatment
      • 5.3.4. Global Osteoarthritis Pain Drugs by: Route of Administration (Volume)
        • 5.3.4.1. Oral
        • 5.3.4.2. Parenteral
        • 5.3.4.3. Topical
      • 5.3.5. Global Osteoarthritis Pain Drugs by: Distribution Channel (Volume)
        • 5.3.5.1. Hospitals
        • 5.3.5.2. Clinics
        • 5.3.5.3. Household
      • 5.3.6. Global Osteoarthritis Pain Drugs by: Dosage Form (Volume)
        • 5.3.6.1. Solid
        • 5.3.6.2. Liquid
        • 5.3.6.3. Semi-Solid
      • 5.3.7. Global Osteoarthritis Pain Drugs by: Drug Class (Volume)
        • 5.3.7.1. Nsaids
        • 5.3.7.2. Opioids
        • 5.3.7.3. Viscosupplements
        • 5.3.7.4. Corticosteroids
        • 5.3.7.5. Others
      • 5.3.8. Global Osteoarthritis Pain Drugs Region
        • 5.3.8.1. South America
          • 5.3.8.1.1. Brazil
          • 5.3.8.1.2. Argentina
          • 5.3.8.1.3. Rest of South America
        • 5.3.8.2. Asia Pacific
          • 5.3.8.2.1. China
          • 5.3.8.2.2. Japan
          • 5.3.8.2.3. India
          • 5.3.8.2.4. South Korea
          • 5.3.8.2.5. Taiwan
          • 5.3.8.2.6. Australia
          • 5.3.8.2.7. Rest of Asia-Pacific
        • 5.3.8.3. Europe
          • 5.3.8.3.1. Germany
          • 5.3.8.3.2. France
          • 5.3.8.3.3. Italy
          • 5.3.8.3.4. United Kingdom
          • 5.3.8.3.5. Netherlands
          • 5.3.8.3.6. Rest of Europe
        • 5.3.8.4. MEA
          • 5.3.8.4.1. Middle East
          • 5.3.8.4.2. Africa
        • 5.3.8.5. North America
          • 5.3.8.5.1. United States
          • 5.3.8.5.2. Canada
          • 5.3.8.5.3. Mexico
    • 5.4. Global Osteoarthritis Pain Drugs (Price)
      • 5.4.1. Global Osteoarthritis Pain Drugs by: Type (Price)
  • 6. Osteoarthritis Pain Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. GlaxoSmithKline (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mylan (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eli Lilly and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Abbott Laboratories (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bioventus, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Sanofi (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Flexion Therapeutics, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Alkem Laboratories (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Anika Therapeutics, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Chugai Pharmaceutical Co.( Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Zimmer Biomet Holdings, Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Osteoarthritis Pain Drugs Sale, by Type, Application, Therapies, Route of Administration, Distribution Channel, Dosage Form, Drug Class and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Osteoarthritis Pain Drugs (Value)
      • 7.2.1. Global Osteoarthritis Pain Drugs by: Type (Value)
        • 7.2.1.1. Oral
        • 7.2.1.2. Injection
        • 7.2.1.3. External
      • 7.2.2. Global Osteoarthritis Pain Drugs by: Application (Value)
        • 7.2.2.1. Medical Care
        • 7.2.2.2. Personal Care
      • 7.2.3. Global Osteoarthritis Pain Drugs by: Therapies (Value)
        • 7.2.3.1. Non- Pharmacological Therapy
        • 7.2.3.2. Pharmacological Therapy
        • 7.2.3.3. Surgical Treatment
      • 7.2.4. Global Osteoarthritis Pain Drugs by: Route of Administration (Value)
        • 7.2.4.1. Oral
        • 7.2.4.2. Parenteral
        • 7.2.4.3. Topical
      • 7.2.5. Global Osteoarthritis Pain Drugs by: Distribution Channel (Value)
        • 7.2.5.1. Hospitals
        • 7.2.5.2. Clinics
        • 7.2.5.3. Household
      • 7.2.6. Global Osteoarthritis Pain Drugs by: Dosage Form (Value)
        • 7.2.6.1. Solid
        • 7.2.6.2. Liquid
        • 7.2.6.3. Semi-Solid
      • 7.2.7. Global Osteoarthritis Pain Drugs by: Drug Class (Value)
        • 7.2.7.1. Nsaids
        • 7.2.7.2. Opioids
        • 7.2.7.3. Viscosupplements
        • 7.2.7.4. Corticosteroids
        • 7.2.7.5. Others
      • 7.2.8. Global Osteoarthritis Pain Drugs Region
        • 7.2.8.1. South America
          • 7.2.8.1.1. Brazil
          • 7.2.8.1.2. Argentina
          • 7.2.8.1.3. Rest of South America
        • 7.2.8.2. Asia Pacific
          • 7.2.8.2.1. China
          • 7.2.8.2.2. Japan
          • 7.2.8.2.3. India
          • 7.2.8.2.4. South Korea
          • 7.2.8.2.5. Taiwan
          • 7.2.8.2.6. Australia
          • 7.2.8.2.7. Rest of Asia-Pacific
        • 7.2.8.3. Europe
          • 7.2.8.3.1. Germany
          • 7.2.8.3.2. France
          • 7.2.8.3.3. Italy
          • 7.2.8.3.4. United Kingdom
          • 7.2.8.3.5. Netherlands
          • 7.2.8.3.6. Rest of Europe
        • 7.2.8.4. MEA
          • 7.2.8.4.1. Middle East
          • 7.2.8.4.2. Africa
        • 7.2.8.5. North America
          • 7.2.8.5.1. United States
          • 7.2.8.5.2. Canada
          • 7.2.8.5.3. Mexico
    • 7.3. Global Osteoarthritis Pain Drugs (Volume)
      • 7.3.1. Global Osteoarthritis Pain Drugs by: Type (Volume)
        • 7.3.1.1. Oral
        • 7.3.1.2. Injection
        • 7.3.1.3. External
      • 7.3.2. Global Osteoarthritis Pain Drugs by: Application (Volume)
        • 7.3.2.1. Medical Care
        • 7.3.2.2. Personal Care
      • 7.3.3. Global Osteoarthritis Pain Drugs by: Therapies (Volume)
        • 7.3.3.1. Non- Pharmacological Therapy
        • 7.3.3.2. Pharmacological Therapy
        • 7.3.3.3. Surgical Treatment
      • 7.3.4. Global Osteoarthritis Pain Drugs by: Route of Administration (Volume)
        • 7.3.4.1. Oral
        • 7.3.4.2. Parenteral
        • 7.3.4.3. Topical
      • 7.3.5. Global Osteoarthritis Pain Drugs by: Distribution Channel (Volume)
        • 7.3.5.1. Hospitals
        • 7.3.5.2. Clinics
        • 7.3.5.3. Household
      • 7.3.6. Global Osteoarthritis Pain Drugs by: Dosage Form (Volume)
        • 7.3.6.1. Solid
        • 7.3.6.2. Liquid
        • 7.3.6.3. Semi-Solid
      • 7.3.7. Global Osteoarthritis Pain Drugs by: Drug Class (Volume)
        • 7.3.7.1. Nsaids
        • 7.3.7.2. Opioids
        • 7.3.7.3. Viscosupplements
        • 7.3.7.4. Corticosteroids
        • 7.3.7.5. Others
      • 7.3.8. Global Osteoarthritis Pain Drugs Region
        • 7.3.8.1. South America
          • 7.3.8.1.1. Brazil
          • 7.3.8.1.2. Argentina
          • 7.3.8.1.3. Rest of South America
        • 7.3.8.2. Asia Pacific
          • 7.3.8.2.1. China
          • 7.3.8.2.2. Japan
          • 7.3.8.2.3. India
          • 7.3.8.2.4. South Korea
          • 7.3.8.2.5. Taiwan
          • 7.3.8.2.6. Australia
          • 7.3.8.2.7. Rest of Asia-Pacific
        • 7.3.8.3. Europe
          • 7.3.8.3.1. Germany
          • 7.3.8.3.2. France
          • 7.3.8.3.3. Italy
          • 7.3.8.3.4. United Kingdom
          • 7.3.8.3.5. Netherlands
          • 7.3.8.3.6. Rest of Europe
        • 7.3.8.4. MEA
          • 7.3.8.4.1. Middle East
          • 7.3.8.4.2. Africa
        • 7.3.8.5. North America
          • 7.3.8.5.1. United States
          • 7.3.8.5.2. Canada
          • 7.3.8.5.3. Mexico
    • 7.4. Global Osteoarthritis Pain Drugs (Price)
      • 7.4.1. Global Osteoarthritis Pain Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Osteoarthritis Pain Drugs: by Type(USD Million)
  • Table 2. Osteoarthritis Pain Drugs Oral , by Region USD Million (2015-2020)
  • Table 3. Osteoarthritis Pain Drugs Injection , by Region USD Million (2015-2020)
  • Table 4. Osteoarthritis Pain Drugs External , by Region USD Million (2015-2020)
  • Table 5. Osteoarthritis Pain Drugs: by Application(USD Million)
  • Table 6. Osteoarthritis Pain Drugs Medical Care , by Region USD Million (2015-2020)
  • Table 7. Osteoarthritis Pain Drugs Personal Care , by Region USD Million (2015-2020)
  • Table 8. Osteoarthritis Pain Drugs: by Therapies(USD Million)
  • Table 9. Osteoarthritis Pain Drugs Non- Pharmacological Therapy , by Region USD Million (2015-2020)
  • Table 10. Osteoarthritis Pain Drugs Pharmacological Therapy , by Region USD Million (2015-2020)
  • Table 11. Osteoarthritis Pain Drugs Surgical Treatment , by Region USD Million (2015-2020)
  • Table 12. Osteoarthritis Pain Drugs: by Route of Administration(USD Million)
  • Table 13. Osteoarthritis Pain Drugs Oral , by Region USD Million (2015-2020)
  • Table 14. Osteoarthritis Pain Drugs Parenteral , by Region USD Million (2015-2020)
  • Table 15. Osteoarthritis Pain Drugs Topical , by Region USD Million (2015-2020)
  • Table 16. Osteoarthritis Pain Drugs: by Distribution Channel(USD Million)
  • Table 17. Osteoarthritis Pain Drugs Hospitals , by Region USD Million (2015-2020)
  • Table 18. Osteoarthritis Pain Drugs Clinics , by Region USD Million (2015-2020)
  • Table 19. Osteoarthritis Pain Drugs Household , by Region USD Million (2015-2020)
  • Table 20. Osteoarthritis Pain Drugs: by Dosage Form(USD Million)
  • Table 21. Osteoarthritis Pain Drugs Solid , by Region USD Million (2015-2020)
  • Table 22. Osteoarthritis Pain Drugs Liquid , by Region USD Million (2015-2020)
  • Table 23. Osteoarthritis Pain Drugs Semi-Solid , by Region USD Million (2015-2020)
  • Table 24. Osteoarthritis Pain Drugs: by Drug Class(USD Million)
  • Table 25. Osteoarthritis Pain Drugs Nsaids , by Region USD Million (2015-2020)
  • Table 26. Osteoarthritis Pain Drugs Opioids , by Region USD Million (2015-2020)
  • Table 27. Osteoarthritis Pain Drugs Viscosupplements , by Region USD Million (2015-2020)
  • Table 28. Osteoarthritis Pain Drugs Corticosteroids , by Region USD Million (2015-2020)
  • Table 29. Osteoarthritis Pain Drugs Others , by Region USD Million (2015-2020)
  • Table 30. South America Osteoarthritis Pain Drugs, by Country USD Million (2015-2020)
  • Table 31. South America Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 32. South America Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 33. South America Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 34. South America Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 35. South America Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 36. South America Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 37. South America Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 38. Brazil Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 39. Brazil Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 40. Brazil Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 41. Brazil Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 42. Brazil Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 43. Brazil Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 44. Brazil Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 45. Argentina Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 46. Argentina Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 47. Argentina Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 48. Argentina Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 49. Argentina Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 50. Argentina Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 51. Argentina Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 52. Rest of South America Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 53. Rest of South America Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 54. Rest of South America Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 55. Rest of South America Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 56. Rest of South America Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 57. Rest of South America Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 58. Rest of South America Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 59. Asia Pacific Osteoarthritis Pain Drugs, by Country USD Million (2015-2020)
  • Table 60. Asia Pacific Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 61. Asia Pacific Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 62. Asia Pacific Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 63. Asia Pacific Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 64. Asia Pacific Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 65. Asia Pacific Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 66. Asia Pacific Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 67. China Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 68. China Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 69. China Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 70. China Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 71. China Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 72. China Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 73. China Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 74. Japan Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 75. Japan Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 76. Japan Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 77. Japan Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 78. Japan Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 79. Japan Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 80. Japan Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 81. India Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 82. India Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 83. India Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 84. India Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 85. India Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 86. India Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 87. India Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 88. South Korea Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 89. South Korea Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 90. South Korea Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 91. South Korea Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 92. South Korea Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 93. South Korea Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 94. South Korea Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 95. Taiwan Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 96. Taiwan Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 97. Taiwan Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 98. Taiwan Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 99. Taiwan Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 100. Taiwan Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 101. Taiwan Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 102. Australia Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 103. Australia Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 104. Australia Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 105. Australia Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 106. Australia Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 107. Australia Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 108. Australia Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 109. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 110. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 111. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 112. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 113. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 114. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 115. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 116. Europe Osteoarthritis Pain Drugs, by Country USD Million (2015-2020)
  • Table 117. Europe Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 118. Europe Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 119. Europe Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 120. Europe Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 121. Europe Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 122. Europe Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 123. Europe Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 124. Germany Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 125. Germany Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 126. Germany Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 127. Germany Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 128. Germany Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 129. Germany Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 130. Germany Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 131. France Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 132. France Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 133. France Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 134. France Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 135. France Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 136. France Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 137. France Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 138. Italy Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 139. Italy Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 140. Italy Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 141. Italy Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 142. Italy Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 143. Italy Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 144. Italy Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 145. United Kingdom Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 146. United Kingdom Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 147. United Kingdom Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 148. United Kingdom Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 149. United Kingdom Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 150. United Kingdom Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 151. United Kingdom Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 152. Netherlands Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 153. Netherlands Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 154. Netherlands Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 155. Netherlands Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 156. Netherlands Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 157. Netherlands Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 158. Netherlands Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 159. Rest of Europe Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 160. Rest of Europe Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 161. Rest of Europe Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 162. Rest of Europe Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 163. Rest of Europe Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 164. Rest of Europe Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 165. Rest of Europe Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 166. MEA Osteoarthritis Pain Drugs, by Country USD Million (2015-2020)
  • Table 167. MEA Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 168. MEA Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 169. MEA Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 170. MEA Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 171. MEA Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 172. MEA Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 173. MEA Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 174. Middle East Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 175. Middle East Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 176. Middle East Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 177. Middle East Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 178. Middle East Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 179. Middle East Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 180. Middle East Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 181. Africa Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 182. Africa Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 183. Africa Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 184. Africa Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 185. Africa Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 186. Africa Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 187. Africa Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 188. North America Osteoarthritis Pain Drugs, by Country USD Million (2015-2020)
  • Table 189. North America Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 190. North America Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 191. North America Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 192. North America Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 193. North America Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 194. North America Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 195. North America Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 196. United States Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 197. United States Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 198. United States Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 199. United States Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 200. United States Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 201. United States Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 202. United States Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 203. Canada Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 204. Canada Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 205. Canada Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 206. Canada Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 207. Canada Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 208. Canada Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 209. Canada Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 210. Mexico Osteoarthritis Pain Drugs, by Type USD Million (2015-2020)
  • Table 211. Mexico Osteoarthritis Pain Drugs, by Application USD Million (2015-2020)
  • Table 212. Mexico Osteoarthritis Pain Drugs, by Therapies USD Million (2015-2020)
  • Table 213. Mexico Osteoarthritis Pain Drugs, by Route of Administration USD Million (2015-2020)
  • Table 214. Mexico Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 215. Mexico Osteoarthritis Pain Drugs, by Dosage Form USD Million (2015-2020)
  • Table 216. Mexico Osteoarthritis Pain Drugs, by Drug Class USD Million (2015-2020)
  • Table 217. Osteoarthritis Pain Drugs Sales: by Type(Unit)
  • Table 218. Osteoarthritis Pain Drugs Sales Oral , by Region Unit (2015-2020)
  • Table 219. Osteoarthritis Pain Drugs Sales Injection , by Region Unit (2015-2020)
  • Table 220. Osteoarthritis Pain Drugs Sales External , by Region Unit (2015-2020)
  • Table 221. Osteoarthritis Pain Drugs Sales: by Application(Unit)
  • Table 222. Osteoarthritis Pain Drugs Sales Medical Care , by Region Unit (2015-2020)
  • Table 223. Osteoarthritis Pain Drugs Sales Personal Care , by Region Unit (2015-2020)
  • Table 224. Osteoarthritis Pain Drugs Sales: by Therapies(Unit)
  • Table 225. Osteoarthritis Pain Drugs Sales Non- Pharmacological Therapy , by Region Unit (2015-2020)
  • Table 226. Osteoarthritis Pain Drugs Sales Pharmacological Therapy , by Region Unit (2015-2020)
  • Table 227. Osteoarthritis Pain Drugs Sales Surgical Treatment , by Region Unit (2015-2020)
  • Table 228. Osteoarthritis Pain Drugs Sales: by Route of Administration(Unit)
  • Table 229. Osteoarthritis Pain Drugs Sales Oral , by Region Unit (2015-2020)
  • Table 230. Osteoarthritis Pain Drugs Sales Parenteral , by Region Unit (2015-2020)
  • Table 231. Osteoarthritis Pain Drugs Sales Topical , by Region Unit (2015-2020)
  • Table 232. Osteoarthritis Pain Drugs Sales: by Distribution Channel(Unit)
  • Table 233. Osteoarthritis Pain Drugs Sales Hospitals , by Region Unit (2015-2020)
  • Table 234. Osteoarthritis Pain Drugs Sales Clinics , by Region Unit (2015-2020)
  • Table 235. Osteoarthritis Pain Drugs Sales Household , by Region Unit (2015-2020)
  • Table 236. Osteoarthritis Pain Drugs Sales: by Dosage Form(Unit)
  • Table 237. Osteoarthritis Pain Drugs Sales Solid , by Region Unit (2015-2020)
  • Table 238. Osteoarthritis Pain Drugs Sales Liquid , by Region Unit (2015-2020)
  • Table 239. Osteoarthritis Pain Drugs Sales Semi-Solid , by Region Unit (2015-2020)
  • Table 240. Osteoarthritis Pain Drugs Sales: by Drug Class(Unit)
  • Table 241. Osteoarthritis Pain Drugs Sales Nsaids , by Region Unit (2015-2020)
  • Table 242. Osteoarthritis Pain Drugs Sales Opioids , by Region Unit (2015-2020)
  • Table 243. Osteoarthritis Pain Drugs Sales Viscosupplements , by Region Unit (2015-2020)
  • Table 244. Osteoarthritis Pain Drugs Sales Corticosteroids , by Region Unit (2015-2020)
  • Table 245. Osteoarthritis Pain Drugs Sales Others , by Region Unit (2015-2020)
  • Table 246. South America Osteoarthritis Pain Drugs Sales, by Country Unit (2015-2020)
  • Table 247. South America Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 248. South America Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 249. South America Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 250. South America Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 251. South America Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 252. South America Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 253. South America Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 254. Brazil Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 255. Brazil Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 256. Brazil Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 257. Brazil Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 258. Brazil Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 259. Brazil Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 260. Brazil Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 261. Argentina Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 262. Argentina Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 263. Argentina Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 264. Argentina Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 265. Argentina Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 266. Argentina Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 267. Argentina Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 268. Rest of South America Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 269. Rest of South America Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 270. Rest of South America Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 271. Rest of South America Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 272. Rest of South America Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 273. Rest of South America Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 274. Rest of South America Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 275. Asia Pacific Osteoarthritis Pain Drugs Sales, by Country Unit (2015-2020)
  • Table 276. Asia Pacific Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 277. Asia Pacific Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 278. Asia Pacific Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 279. Asia Pacific Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 280. Asia Pacific Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 281. Asia Pacific Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 282. Asia Pacific Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 283. China Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 284. China Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 285. China Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 286. China Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 287. China Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 288. China Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 289. China Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 290. Japan Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 291. Japan Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 292. Japan Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 293. Japan Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 294. Japan Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 295. Japan Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 296. Japan Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 297. India Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 298. India Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 299. India Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 300. India Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 301. India Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 302. India Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 303. India Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 304. South Korea Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 305. South Korea Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 306. South Korea Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 307. South Korea Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 308. South Korea Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 309. South Korea Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 310. South Korea Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 311. Taiwan Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 312. Taiwan Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 313. Taiwan Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 314. Taiwan Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 315. Taiwan Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 316. Taiwan Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 317. Taiwan Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 318. Australia Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 319. Australia Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 320. Australia Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 321. Australia Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 322. Australia Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 323. Australia Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 324. Australia Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 325. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 326. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 327. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 328. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 329. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 330. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 331. Rest of Asia-Pacific Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 332. Europe Osteoarthritis Pain Drugs Sales, by Country Unit (2015-2020)
  • Table 333. Europe Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 334. Europe Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 335. Europe Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 336. Europe Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 337. Europe Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 338. Europe Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 339. Europe Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 340. Germany Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 341. Germany Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 342. Germany Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 343. Germany Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 344. Germany Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 345. Germany Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 346. Germany Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 347. France Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 348. France Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 349. France Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 350. France Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 351. France Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 352. France Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 353. France Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 354. Italy Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 355. Italy Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 356. Italy Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 357. Italy Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 358. Italy Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 359. Italy Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 360. Italy Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 361. United Kingdom Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 362. United Kingdom Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 363. United Kingdom Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 364. United Kingdom Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 365. United Kingdom Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 366. United Kingdom Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 367. United Kingdom Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 368. Netherlands Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 369. Netherlands Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 370. Netherlands Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 371. Netherlands Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 372. Netherlands Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 373. Netherlands Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 374. Netherlands Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 375. Rest of Europe Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 376. Rest of Europe Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 377. Rest of Europe Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 378. Rest of Europe Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 379. Rest of Europe Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 380. Rest of Europe Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 381. Rest of Europe Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 382. MEA Osteoarthritis Pain Drugs Sales, by Country Unit (2015-2020)
  • Table 383. MEA Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 384. MEA Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 385. MEA Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 386. MEA Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 387. MEA Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 388. MEA Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 389. MEA Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 390. Middle East Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 391. Middle East Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 392. Middle East Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 393. Middle East Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 394. Middle East Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 395. Middle East Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 396. Middle East Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 397. Africa Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 398. Africa Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 399. Africa Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 400. Africa Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 401. Africa Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 402. Africa Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 403. Africa Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 404. North America Osteoarthritis Pain Drugs Sales, by Country Unit (2015-2020)
  • Table 405. North America Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 406. North America Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 407. North America Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 408. North America Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 409. North America Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 410. North America Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 411. North America Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 412. United States Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 413. United States Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 414. United States Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 415. United States Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 416. United States Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 417. United States Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 418. United States Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 419. Canada Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 420. Canada Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 421. Canada Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 422. Canada Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 423. Canada Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 424. Canada Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 425. Canada Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 426. Mexico Osteoarthritis Pain Drugs Sales, by Type Unit (2015-2020)
  • Table 427. Mexico Osteoarthritis Pain Drugs Sales, by Application Unit (2015-2020)
  • Table 428. Mexico Osteoarthritis Pain Drugs Sales, by Therapies Unit (2015-2020)
  • Table 429. Mexico Osteoarthritis Pain Drugs Sales, by Route of Administration Unit (2015-2020)
  • Table 430. Mexico Osteoarthritis Pain Drugs Sales, by Distribution Channel Unit (2015-2020)
  • Table 431. Mexico Osteoarthritis Pain Drugs Sales, by Dosage Form Unit (2015-2020)
  • Table 432. Mexico Osteoarthritis Pain Drugs Sales, by Drug Class Unit (2015-2020)
  • Table 433. Osteoarthritis Pain Drugs: by Type(USD/Units)
  • Table 434. Company Basic Information, Sales Area and Its Competitors
  • Table 435. Company Basic Information, Sales Area and Its Competitors
  • Table 436. Company Basic Information, Sales Area and Its Competitors
  • Table 437. Company Basic Information, Sales Area and Its Competitors
  • Table 438. Company Basic Information, Sales Area and Its Competitors
  • Table 439. Company Basic Information, Sales Area and Its Competitors
  • Table 440. Company Basic Information, Sales Area and Its Competitors
  • Table 441. Company Basic Information, Sales Area and Its Competitors
  • Table 442. Company Basic Information, Sales Area and Its Competitors
  • Table 443. Company Basic Information, Sales Area and Its Competitors
  • Table 444. Company Basic Information, Sales Area and Its Competitors
  • Table 445. Company Basic Information, Sales Area and Its Competitors
  • Table 446. Company Basic Information, Sales Area and Its Competitors
  • Table 447. Osteoarthritis Pain Drugs: by Type(USD Million)
  • Table 448. Osteoarthritis Pain Drugs Oral , by Region USD Million (2021-2026)
  • Table 449. Osteoarthritis Pain Drugs Injection , by Region USD Million (2021-2026)
  • Table 450. Osteoarthritis Pain Drugs External , by Region USD Million (2021-2026)
  • Table 451. Osteoarthritis Pain Drugs: by Application(USD Million)
  • Table 452. Osteoarthritis Pain Drugs Medical Care , by Region USD Million (2021-2026)
  • Table 453. Osteoarthritis Pain Drugs Personal Care , by Region USD Million (2021-2026)
  • Table 454. Osteoarthritis Pain Drugs: by Therapies(USD Million)
  • Table 455. Osteoarthritis Pain Drugs Non- Pharmacological Therapy , by Region USD Million (2021-2026)
  • Table 456. Osteoarthritis Pain Drugs Pharmacological Therapy , by Region USD Million (2021-2026)
  • Table 457. Osteoarthritis Pain Drugs Surgical Treatment , by Region USD Million (2021-2026)
  • Table 458. Osteoarthritis Pain Drugs: by Route of Administration(USD Million)
  • Table 459. Osteoarthritis Pain Drugs Oral , by Region USD Million (2021-2026)
  • Table 460. Osteoarthritis Pain Drugs Parenteral , by Region USD Million (2021-2026)
  • Table 461. Osteoarthritis Pain Drugs Topical , by Region USD Million (2021-2026)
  • Table 462. Osteoarthritis Pain Drugs: by Distribution Channel(USD Million)
  • Table 463. Osteoarthritis Pain Drugs Hospitals , by Region USD Million (2021-2026)
  • Table 464. Osteoarthritis Pain Drugs Clinics , by Region USD Million (2021-2026)
  • Table 465. Osteoarthritis Pain Drugs Household , by Region USD Million (2021-2026)
  • Table 466. Osteoarthritis Pain Drugs: by Dosage Form(USD Million)
  • Table 467. Osteoarthritis Pain Drugs Solid , by Region USD Million (2021-2026)
  • Table 468. Osteoarthritis Pain Drugs Liquid , by Region USD Million (2021-2026)
  • Table 469. Osteoarthritis Pain Drugs Semi-Solid , by Region USD Million (2021-2026)
  • Table 470. Osteoarthritis Pain Drugs: by Drug Class(USD Million)
  • Table 471. Osteoarthritis Pain Drugs Nsaids , by Region USD Million (2021-2026)
  • Table 472. Osteoarthritis Pain Drugs Opioids , by Region USD Million (2021-2026)
  • Table 473. Osteoarthritis Pain Drugs Viscosupplements , by Region USD Million (2021-2026)
  • Table 474. Osteoarthritis Pain Drugs Corticosteroids , by Region USD Million (2021-2026)
  • Table 475. Osteoarthritis Pain Drugs Others , by Region USD Million (2021-2026)
  • Table 476. South America Osteoarthritis Pain Drugs, by Country USD Million (2021-2026)
  • Table 477. South America Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 478. South America Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 479. South America Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 480. South America Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 481. South America Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 482. South America Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 483. South America Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 484. Brazil Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 485. Brazil Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 486. Brazil Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 487. Brazil Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 488. Brazil Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 489. Brazil Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 490. Brazil Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 491. Argentina Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 492. Argentina Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 493. Argentina Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 494. Argentina Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 495. Argentina Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 496. Argentina Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 497. Argentina Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 498. Rest of South America Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 499. Rest of South America Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 500. Rest of South America Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 501. Rest of South America Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 502. Rest of South America Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 503. Rest of South America Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 504. Rest of South America Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 505. Asia Pacific Osteoarthritis Pain Drugs, by Country USD Million (2021-2026)
  • Table 506. Asia Pacific Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 507. Asia Pacific Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 508. Asia Pacific Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 509. Asia Pacific Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 510. Asia Pacific Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 511. Asia Pacific Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 512. Asia Pacific Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 513. China Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 514. China Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 515. China Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 516. China Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 517. China Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 518. China Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 519. China Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 520. Japan Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 521. Japan Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 522. Japan Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 523. Japan Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 524. Japan Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 525. Japan Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 526. Japan Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 527. India Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 528. India Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 529. India Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 530. India Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 531. India Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 532. India Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 533. India Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 534. South Korea Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 535. South Korea Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 536. South Korea Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 537. South Korea Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 538. South Korea Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 539. South Korea Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 540. South Korea Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 541. Taiwan Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 542. Taiwan Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 543. Taiwan Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 544. Taiwan Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 545. Taiwan Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 546. Taiwan Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 547. Taiwan Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 548. Australia Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 549. Australia Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 550. Australia Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 551. Australia Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 552. Australia Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 553. Australia Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 554. Australia Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 555. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 556. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 557. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 558. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 559. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 560. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 561. Rest of Asia-Pacific Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 562. Europe Osteoarthritis Pain Drugs, by Country USD Million (2021-2026)
  • Table 563. Europe Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 564. Europe Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 565. Europe Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 566. Europe Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 567. Europe Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 568. Europe Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 569. Europe Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 570. Germany Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 571. Germany Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 572. Germany Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 573. Germany Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 574. Germany Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 575. Germany Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 576. Germany Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 577. France Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 578. France Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 579. France Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 580. France Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 581. France Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 582. France Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 583. France Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 584. Italy Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 585. Italy Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 586. Italy Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 587. Italy Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 588. Italy Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 589. Italy Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 590. Italy Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 591. United Kingdom Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 592. United Kingdom Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 593. United Kingdom Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 594. United Kingdom Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 595. United Kingdom Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 596. United Kingdom Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 597. United Kingdom Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 598. Netherlands Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 599. Netherlands Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 600. Netherlands Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 601. Netherlands Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 602. Netherlands Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 603. Netherlands Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 604. Netherlands Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 605. Rest of Europe Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 606. Rest of Europe Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 607. Rest of Europe Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 608. Rest of Europe Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 609. Rest of Europe Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 610. Rest of Europe Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 611. Rest of Europe Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 612. MEA Osteoarthritis Pain Drugs, by Country USD Million (2021-2026)
  • Table 613. MEA Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 614. MEA Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 615. MEA Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 616. MEA Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 617. MEA Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 618. MEA Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 619. MEA Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 620. Middle East Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 621. Middle East Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 622. Middle East Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 623. Middle East Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 624. Middle East Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 625. Middle East Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 626. Middle East Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 627. Africa Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 628. Africa Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 629. Africa Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 630. Africa Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 631. Africa Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 632. Africa Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 633. Africa Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 634. North America Osteoarthritis Pain Drugs, by Country USD Million (2021-2026)
  • Table 635. North America Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 636. North America Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 637. North America Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 638. North America Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 639. North America Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 640. North America Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 641. North America Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 642. United States Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 643. United States Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 644. United States Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 645. United States Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 646. United States Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 647. United States Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 648. United States Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 649. Canada Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 650. Canada Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 651. Canada Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 652. Canada Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 653. Canada Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 654. Canada Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 655. Canada Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 656. Mexico Osteoarthritis Pain Drugs, by Type USD Million (2021-2026)
  • Table 657. Mexico Osteoarthritis Pain Drugs, by Application USD Million (2021-2026)
  • Table 658. Mexico Osteoarthritis Pain Drugs, by Therapies USD Million (2021-2026)
  • Table 659. Mexico Osteoarthritis Pain Drugs, by Route of Administration USD Million (2021-2026)
  • Table 660. Mexico Osteoarthritis Pain Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 661. Mexico Osteoarthritis Pain Drugs, by Dosage Form USD Million (2021-2026)
  • Table 662. Mexico Osteoarthritis Pain Drugs, by Drug Class USD Million (2021-2026)
  • Table 663. Osteoarthritis Pain Drugs Sales: by Type(Unit)
  • Table 664. Osteoarthritis Pain Drugs Sales Oral , by Region Unit (2021-2026)
  • Table 665. Osteoarthritis Pain Drugs Sales Injection , by Region Unit (2021-2026)
  • Table 666. Osteoarthritis Pain Drugs Sales External , by Region Unit (2021-2026)
  • Table 667. Osteoarthritis Pain Drugs Sales: by Application(Unit)
  • Table 668. Osteoarthritis Pain Drugs Sales Medical Care , by Region Unit (2021-2026)
  • Table 669. Osteoarthritis Pain Drugs Sales Personal Care , by Region Unit (2021-2026)
  • Table 670. Osteoarthritis Pain Drugs Sales: by Therapies(Unit)
  • Table 671. Osteoarthritis Pain Drugs Sales Non- Pharmacological Therapy , by Region Unit (2021-2026)
  • Table 672. Osteoarthritis Pain Drugs Sales Pharmacological Therapy , by Region Unit (2021-2026)
  • Table 673. Osteoarthritis Pain Drugs Sales Surgical Treatment , by Region Unit (2021-2026)
  • Table 674. Osteoarthritis Pain Drugs Sales: by Route of Administration(Unit)
  • Table 675. Osteoarthritis Pain Drugs Sales Oral , by Region Unit (2021-2026)
  • Table 676. Osteoarthritis Pain Drugs Sales Parenteral , by Region Unit (2021-2026)
  • Table 677. Osteoarthritis Pain Drugs Sales Topical , by Region Unit (2021-2026)
  • Table 678. Osteoarthritis Pain Drugs Sales: by Distribution Channel(Unit)
  • Table 679. Osteoarthritis Pain Drugs Sales Hospitals , by Region Unit (2021-2026)
  • Table 680. Osteoarthritis Pain Drugs Sales Clinics , by Region Unit (2021-2026)
  • Table 681. Osteoarthritis Pain Drugs Sales Household , by Region Unit (2021-2026)
  • Table 682. Osteoarthritis Pain Drugs Sales: by Dosage Form(Unit)
  • Table 683. Osteoarthritis Pain Drugs Sales Solid , by Region Unit (2021-2026)
  • Table 684. Osteoarthritis Pain Drugs Sales Liquid , by Region Unit (2021-2026)
  • Table 685. Osteoarthritis Pain Drugs Sales Semi-Solid , by Region Unit (2021-2026)
  • Table 686. Osteoarthritis Pain Drugs Sales: by Drug Class(Unit)
  • Table 687. Osteoarthritis Pain Drugs Sales Nsaids , by Region Unit (2021-2026)
  • Table 688. Osteoarthritis Pain Drugs Sales Opioids , by Region Unit (2021-2026)
  • Table 689. Osteoarthritis Pain Drugs Sales Viscosupplements , by Region Unit (2021-2026)
  • Table 690. Osteoarthritis Pain Drugs Sales Corticosteroids , by Region Unit (2021-2026)
  • Table 691. Osteoarthritis Pain Drugs Sales Others , by Region Unit (2021-2026)
  • Table 692. South America Osteoarthritis Pain Drugs Sales, by Country Unit (2021-2026)
  • Table 693. South America Osteoarthritis Pain Drugs Sales, by Type Unit (2021-2026)
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Osteoarthritis Pain Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Osteoarthritis Pain Drugs: by Application USD Million (2015-2020)
  • Figure 6. Global Osteoarthritis Pain Drugs: by Therapies USD Million (2015-2020)
  • Figure 7. Global Osteoarthritis Pain Drugs: by Route of Administration USD Million (2015-2020)
  • Figure 8. Global Osteoarthritis Pain Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 9. Global Osteoarthritis Pain Drugs: by Dosage Form USD Million (2015-2020)
  • Figure 10. Global Osteoarthritis Pain Drugs: by Drug Class USD Million (2015-2020)
  • Figure 11. South America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 12. Asia Pacific Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 13. Europe Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 14. MEA Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 15. North America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 16. Global Osteoarthritis Pain Drugs: by Type Unit (2015-2020)
  • Figure 17. Global Osteoarthritis Pain Drugs: by Application Unit (2015-2020)
  • Figure 18. Global Osteoarthritis Pain Drugs: by Therapies Unit (2015-2020)
  • Figure 19. Global Osteoarthritis Pain Drugs: by Route of Administration Unit (2015-2020)
  • Figure 20. Global Osteoarthritis Pain Drugs: by Distribution Channel Unit (2015-2020)
  • Figure 21. Global Osteoarthritis Pain Drugs: by Dosage Form Unit (2015-2020)
  • Figure 22. Global Osteoarthritis Pain Drugs: by Drug Class Unit (2015-2020)
  • Figure 23. South America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 24. Asia Pacific Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 25. Europe Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 26. MEA Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 27. North America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 28. Global Osteoarthritis Pain Drugs: by Type USD/Units (2015-2020)
  • Figure 29. Global Osteoarthritis Pain Drugs share by Players 2020 (%)
  • Figure 30. Global Osteoarthritis Pain Drugs share by Players (Top 3) 2020(%)
  • Figure 31. Global Osteoarthritis Pain Drugs share by Players (Top 5) 2020(%)
  • Figure 32. BCG Matrix for key Companies
  • Figure 33. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 35. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 36. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 37. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2020
  • Figure 39. Mylan (United States) Revenue, Net Income and Gross profit
  • Figure 40. Mylan (United States) Revenue: by Geography 2020
  • Figure 41. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 42. Eli Lilly and Company (United States) Revenue: by Geography 2020
  • Figure 43. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 44. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 45. Bioventus, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Bioventus, Inc. (United States) Revenue: by Geography 2020
  • Figure 47. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 48. Sanofi (France) Revenue: by Geography 2020
  • Figure 49. Flexion Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 50. Flexion Therapeutics, Inc. (United States) Revenue: by Geography 2020
  • Figure 51. Alkem Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 52. Alkem Laboratories (India) Revenue: by Geography 2020
  • Figure 53. Anika Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 54. Anika Therapeutics, Inc. (United States) Revenue: by Geography 2020
  • Figure 55. Chugai Pharmaceutical Co.( Japan) Revenue, Net Income and Gross profit
  • Figure 56. Chugai Pharmaceutical Co.( Japan) Revenue: by Geography 2020
  • Figure 57. Zimmer Biomet Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 58. Zimmer Biomet Holdings, Inc. (United States) Revenue: by Geography 2020
  • Figure 59. Global Osteoarthritis Pain Drugs: by Type USD Million (2021-2026)
  • Figure 60. Global Osteoarthritis Pain Drugs: by Application USD Million (2021-2026)
  • Figure 61. Global Osteoarthritis Pain Drugs: by Therapies USD Million (2021-2026)
  • Figure 62. Global Osteoarthritis Pain Drugs: by Route of Administration USD Million (2021-2026)
  • Figure 63. Global Osteoarthritis Pain Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 64. Global Osteoarthritis Pain Drugs: by Dosage Form USD Million (2021-2026)
  • Figure 65. Global Osteoarthritis Pain Drugs: by Drug Class USD Million (2021-2026)
  • Figure 66. South America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 67. Asia Pacific Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 68. Europe Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 69. MEA Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 70. North America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 71. Global Osteoarthritis Pain Drugs: by Type Unit (2021-2026)
  • Figure 72. Global Osteoarthritis Pain Drugs: by Application Unit (2021-2026)
  • Figure 73. Global Osteoarthritis Pain Drugs: by Therapies Unit (2021-2026)
  • Figure 74. Global Osteoarthritis Pain Drugs: by Route of Administration Unit (2021-2026)
  • Figure 75. Global Osteoarthritis Pain Drugs: by Distribution Channel Unit (2021-2026)
  • Figure 76. Global Osteoarthritis Pain Drugs: by Dosage Form Unit (2021-2026)
  • Figure 77. Global Osteoarthritis Pain Drugs: by Drug Class Unit (2021-2026)
  • Figure 78. South America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 79. Asia Pacific Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 80. Europe Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 81. MEA Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 82. North America Osteoarthritis Pain Drugs Share (%), by Country
  • Figure 83. Global Osteoarthritis Pain Drugs: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Pfizer Inc. (United States)
  • Johnson & Johnson (United States)
  • GlaxoSmithKline (United Kingdom)
  • Mylan (United States)
  • Eli Lilly and Company (United States)
  • Abbott Laboratories (United States)
  • Bioventus, Inc. (United States)
  • Sanofi (France)
  • Flexion Therapeutics, Inc. (United States)
  • Alkem Laboratories (India)
  • Anika Therapeutics, Inc. (United States)
  • Chugai Pharmaceutical Co.( Japan)
  • Zimmer Biomet Holdings, Inc. (United States)
Additional players considered in the study are as follows:
Horizon Pharma Plc (Dublin) , Ferring B.V.(Switzerland) , Bayer (Germany) , Almatica Pharma (United States) , TEVA (Isreal) , Iroko Pharmaceuticals (United States)
Select User Access Type

Key Highlights of Report


Oct 2021 224 Pages 74 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Osteoarthritis Pain Drugs Quantitative research analysis
Global Osteoarthritis Pain Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Rise in Geriatric Population " is seen as one of major growth factors of Osteoarthritis Pain Drugs Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
United States will lead Osteoarthritis Pain Drugs Market in coming years.

Know More About Global Osteoarthritis Pain Drugs Report?

Have a Query? Click Here

Other Related Reports

Docusate Sodium Comprehensive Study by Type (DSS 100%, DSS 85%, DSS 50%), Application (Exicipient, Active Pharmaceutical Ingredients, Constipation, Pesticide adjuvant, Micelle encapsulation), Route o...
$ 3650
Resistant Maltodextrin Comprehensive Study by Type (Corn-based, Wheat-based, Others), Application (Beverages, Bakery & Confectionery, Dairy Products, Nutraceuticals, Others) Players and Region - Glob...
$ 3500
Lansoprazole Comprehensive Study by Type (Capsules, OD Tablet, Injection), Application (Male, Female), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies, Drug stores), R...
$ 3350
Hair Loss and Growth Devices Comprehensive Study by Type (Lasers, LED, Others), Application (Homecare, Hair Loss Treatment Clinic), Gender (Men, Women) Players and Region - Global Market Outlook to 2...
$ 3500
Hormonal Contraceptive Comprehensive Study by Type (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches), Formulations (Combined Meth...
$ 3750
Lectins Comprehensive Study by Type (Above 90%, Above 95%, Above 99%, Others), Application (Bioscience Research Institutions, Biopharmaceutical Companies, Hospitals, Others), End-Use Industry (Health...
$ 3350